Myocardial bioprosthesis: Mimicking nature

Drugs of the Future

Volumn 38, Issue 7, 2013, Pages 475-484

  Soler Botija, C ^a   Galvez Monton C ^a   Prat Vidal, C ^a   Roura, S ^a   Bayes Genis, A ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bioartificial heart; Biomaterials; Cardiac regeneration; Cardiac tissue engineering; Cardiomyoplasty; Myocardial infarction

Indexed keywords

ALGINIC ACID; CHITOSAN; COLLAGEN; COLLAGEN TYPE 4; FIBRIN; FIBRONECTIN; HEPARAN SULFATE; KRUPPEL LIKE FACTOR 4; LAMININ; MACROGOL; OCTAMER TRANSCRIPTION FACTOR 4; POLYCAPROLACTONE; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; TRANSCRIPTION FACTOR SOX2;

ACUTE HEART INFARCTION; ARTIFICIAL HEART; BIOPROSTHESIS; BONE MARROW CELL; CARDIAC IMPLANT; CARDIOMYOPLASTY; CELL THERAPY; EMBRYONIC STEM CELL; EXCITATION CONTRACTION COUPLING; EXTRACELLULAR MATRIX; HEART GRAFT; HEART MUSCLE CELL; HUMAN; HYDROGEL; MESENCHYMAL STEM CELL; MONONUCLEAR CELL; MYOBLAST; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVIEW; SOMATIC CELL; TISSUE ENGINEERING; VASCULARIZATION;

EID: 84930539233     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2013.038.07.1980500     Document Type: Review

References (129)

1. Anversa, P. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res 1991, 68(3): 856-69.
2. Genovese, J., Cortes-Morichetti, M., Chachques, E., Frati, G., Patel, A., Chachques, J.C. Cell based approaches for myocardial regeneration and artificial myocardium. Curr Stem Cell Res Ther 2007, 2(2): 121-7.
3. Chachques, J.C. Cardiomyoplasty: Is it still a viable option in patients with end-stage heart failure? Eur J Cardiothorac Surg 2009, 35(2): 201-3.
4. Orlic, D., Kajstura, J., Chimenti, S., Bodine, D.M., Leri, A., Anversa, P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann NY Acad Sci 2001, 938: 221-9.
5. Leistner, D.M., Fischer-Rasokat, U., Honold, J. et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): Final 5-year results suggest long-term safety and efficacy. Clin Res Cardiol 2011, 100(10): 925-34.
6. Vunjak-Novakovic, G., Lui, K.O., Tandon, N., Chien, K.R. Bioengineering heart muscle: A paradigm for regenerative medicine. Annu Pev Biomed Eng 2011, 13(15): 245-67.
7. Soler-Botija, C., Bago, J.R., Bayes-Genis, A. A bird's-eye view of cell therapy and tissue engineering for cardiac regeneration. Ann N Y Acad Sci 2012, 1254: 57-65.
8. Gálvez-Montón, C., Prat-Vidal, C., Roura, S., Soler-Botija, C., Bayes-Genis, A. Cardiac tissue engineering and the bioartificial heart. Rev Esp Cardiol 2013, 66(5): 391-9.
9. Ott, H.C., Matthiesen, T.S., Goh, S.K., Black, L.D., Kren, S.M., Netoff, T.I., Taylor, D.A. Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat Med 2008, 14(2): 213-21.
10. Beltrami, A.P., Barlucchi, L., Torella, D. et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114(6): 763-76.
11. Oh, H., Bradfute, S.B., Gallardo, T.D. et al. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 2003, 100(21): 12313-8.
12. Laugwitz, K.L., Moretti, A., Lam, J. et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005, 433(1026): 647-53.
13. Smith, R.R., Barile, L., Cho, H.C. et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007, 115(7): 896-908.
14. Rangappa, S., Fen, C., Lee, E.H., Bongso, A., Sim, E.K. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg 2003, 75(3): 775-9.
15. Roura, S., Farré, J., Hove-Madsen, L. et al. Exposure to cardiomyogenic stimuli fails to transdifferentiate human umbilical cord blood-derived mesenchymal stem cells. Basic Res Cardiol 2010, 105(3): 419-30.
16. Vunjak-Novakovic, G., Tandon, N., Godier, A., Maidhof, R., Marsano, A., Martens, T.P., Radisic, M. Challenges in cardiac tissue engineering. Tissue Eng Part B Rev 2010, 16(2): 169-87.
17. Yang, L., Soonpaa, M.H., Adler, E.D. et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008, 453(7194): 524-8.
18. van Laake, L.W., Passier, R., Doevendans, P.A., Mummery, C.L. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res 2008, 102(9): 1008-10.
19. Shiba, Y., Fernandes, S., Zhu, W.Z. et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 2012, 489(7415): 322-5.
20. Cao, F., van der Bogt, K.E., Sadrzadeh, A. et al. Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. Stem Cells Dev 2007, 16(6): 883-91.
21. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131(5): 861-72.
22. Yu, J., Vodyanik, M.A., Smuga-Otto, K. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318(5858): 1917-20.
23. Ivics, Z., Li, M.A., Mátés, L., Boeke, J.D., Nagy, A., Bradley, A., Izsvák, Z. Transposon-mediated genome manipulation in vertebrates. Nat Methods 2009, 6(6): 415-22.
24. Robinton, D.A., Daley, G.Q. The promise of induced pluripotent stem cells in research and therapy. Nature 2012, 481(7381): 295-305.
25. Kim, D., Kim, C.H., Moon, J.I. et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4(6): 472-6.
26. Zhou, H., Wu, S., Joo, J.Y. et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009, 4(5): 381-4.
27. Warren, L., Manos, P.D., Ahfeldt, T. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010, 7(5): 618-30.
28. Kawaguchi, N., Hayama, E., Furutani, Y., Nakanishi, T. Prospective in vitro models of channelopathies and cardiomyopathies. Stem Cells Int 2012, 2012: 439219.
29. Blazeski, A., Zhu, R., Hunter, D.W., Weinberg, S.H., Zambidis, E.T., Tung, L. Cardiomyocytes derived from human induced pluripotent stem cells as models for normal and diseased cardiac electrophysiology and contractility. Prog Biophys Mol Biol 2012, 110(2-3): 166-77.
30. Mauritz, C., Martens, A., Rojas, S.V. et al. Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J 2011, 32(21): 2634-41.
31. Kawamura, M., Miyagawa, S., Miki, K. et al. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 2012, 126(11, Suppl. 1): S29-37.
32. Soonpaa, M.H., Koh, G.Y., Klug, M.G., Field, L.J. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994, 264(5155): 98-101.
33. Etzion, S., Battler, A., Barbash, I.M. et al. Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction. J Mol Cell Cardiol 2001, 33(7): 1321-30.
34. Siminiak, T., Kalawski, R., Fiszer, D., Jerzykowska, O., Rzezniczak, J., Rozwadowska, N., Kurpisz, M. Autologous skeletal myoblast transplantation for the treatment of, postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. Am Heart J 2004, 148(3): 531-7.
35. Jain, M., DerSimonian, H., Brenner, D.A. et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 2001, 103(14): 1920-7.
36. Menasché, P., Alfieri, O., Janssens, S. et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation. Circulation 2008, 117(9): 1189-200.
37. myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002, 106(15): 1913-8.
38. Wollert, K.C., Meyer, G.P., Lotz, J. et al. Intracoronary autologous bonemarrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004, 364(9429): 141-8.
39. Traverse, J.H., Henry, T.D., Pepine, C.J. et al. Cardiovascular Cell Therapy Research Network (CCTRN): Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: The TIME randomized trial. JAMA 2012, 308(22): 2380-9.
40. Perin, E.C., Willerson, J.T., Pepine, C.J. et al. Cardiovascular Cell Therapy Research Network (CCTRN): Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: The FOCUS-CCTRN trial. JAMA 2012, 307(16): 1717-26.
41. Bayes-Genis, A., Roura, S., Soler-Botija, C., Farré, J., Hove-Madsen, L., Llach, A., Cinca, J. Identification of cardiomyogenic lineage markers in untreated human bone marrow-derived mesenchymal stem cells. Transplant Proc 2005, 37(9): 4077-9.
42. Prat-Vidal, C., Roura, S., Farré, J. et al. Umbilical cord blood-derived stem cells spontaneously express cardiomyogenic traits. Transplant Proc 2007, 39(7): 2434-7.
43. Roura, S., Pujal, J.M., Bayes-Genis, A. Umbilical cord blood for cardiovascular cell therapy: From promise to fact. Ann N Y Acad Sci 2012, 1254: 66-70.
44. Roura, S., Bagó, J.R., Soler-Botija, C. et al. Human umbilical cord bloodderived mesenchymal stem cells promote vascular growth in vivo. PLoS ONE 2012, 7(11): e49447.
45. Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., Ringden, O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003, 31(10): 890-6.
46. Shake, J.G., Gruber, P.J., Baumgartner, W.A. et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann Thorac Surg 2002, 73(6): 1919-25.
47. Grinnemo, K.H., Månsson-Broberg, A., Leblanc, K. et al. Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel. Ann Med 2006, 38(2): 144-53.
48. Wei, F., Wang, T.Z., Zhang, J. et al. Mesenchymal stem cells neither fully acquire the electrophysiological properties of mature cardiomyocytes nor promote ventricular arrhythmias in infarcted rats. Basic Res Cardiol 2012, 107(4): 274.
49. Wollert, K.C., Meyer, G.P., Lotz, J. et al. Intracoronary autologous bonemarrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004, 364(9429): 141-8.
50. Yang, Z., Zhang, F., Ma, W. et al. A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: Delivery via a noninfarct-relative artery. Cardiovasc Ther 2010, 28(6): 380-5.
51. Lunde, K., Solheim, S., Aakhus, S. et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006, 355(12): 1199-209.
52. Schachinger, V., Erbs, S., Elsässer, A. et al. Intracoronary bone marrowderived progenitor cells in acute myocardial infarction. N Engl J Med 2006, 355(12): 1210-21.
53. Breitbach, M., Bostani, T., Roell, W. et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007, 110(4): 1362-9.
54. Gimble, J.M., Katz, A.J., Bunnell, B.A. Adipose-derived stem cells for regenerative medicine. Circ Res 2007, 100(9): 1249-60.
55. Rangappa, S., Fen, C., Lee, E.H., Bongso, A., Sim, E.K. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg 2003, 75(3): 775-9.
56. Planat-Bénard, V., Menard, C., André, M. et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 2004, 94(2): 223-9.
57. Léobon, B., Roncalli, J., Joffre, C. et al. Adipose-derived cardiomyogenic cells: In vitro expansion and functional improvement in a mouse model of myocardial infarction. Cardiovasc Res 2009, 83(4): 757-67.
58. Rigol, M., Solanes, N., Farré, J. et al. Effects of adipose tissue-derived stem cell therapy after myocardial infarction: Impact on the route of administration. J Card Fail 2010, 16(4): 357-66.
59. Meliga, E., Strem, B.M., Duckers, H.J., Serruys, P.W. Adipose-derived cells. Cell Transplant 2007, 16(9): 963-70.
60. Houtgraaf, J.H., den Dekker, W.K., van Dalen, B.M. et al. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2012, 59(5): 539-40.
61. Bayes-Genis, A., Soler-Botija, C., Farré, J. et al. Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. J Mol Cell Cardiol 2010, 49(5): 771-80.
62. Assmus, B., Schachinger, V., Teupe, C. et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002, 106(24): 3009-17.
63. Martin, C.M., Meeson, A.P., Robertson, S.M. et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol 2004, 265(1): 262-75.
64. Messina, E., De Angelis, L., Frati, G. et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004, 95(9): 911-21.
65. Bock-Marquette, I., Saxena, A., White, M.D., Dimaio, J.M., Srivastava, D. Thymosin beta4 activates integrin linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 2004, 432(7016): 466-72.
66. Linke, A., Muller, P., Nurzynska, D. et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A 2005, 102(25): 8966-71.
67. Li, T.S., Mikamo, A., Takahashi, M. et al. Comparison of cell therapy and cytokine therapy for functional repair in ischemic and nonischemic heart failure. Cell Transplant 2007, 16(4): 365-74.
68. Janssens, S. Dubois, C., Bogaert, J. et al. Autologous bone marrowderived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet 2006, 367(9505): 113-21.
69. Mathiasen, A.B., Jørgensen, E., Qayyum, A.A., Haack- Sørensen, M., Ekblond, A., Kastrup, J. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived mesenchymal stromal cells in chronic ischemic heart failure (MSC-HF Trial). Am Heart J 2012, 164(3): 285-91.
70. Hashemi, S.M., Ghods, S., Kolodgie, F.D. et al. A placebo controlled, doseranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J 2008, 29(2): 251-9.
71. Hou, D., Youssef, E.A., Brinton, T.J. et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: Implications for current clinical trials. Circulation 2005, 112(9, Suppl.): I150-6.
72. Vunjak-Novakovic, G., Lui, K.O., Tandon, N., Chien, K.R. Bioengineering heart muscle: A paradigm for regenerative medicine. Annu Pev Biomed Eng 2011, 13: 245-67.
73. Lunkenheimer, P.P., Redmann, K., Westermann, P., Rothaus, K., Cryer, C.W., Niederer, P., Anderson, R.H. The myocardium and its fibrous matrix working in concert as a spatially netted mesh: A critical review of the purported tertiary structure of the ventricular mass. Eur J Cardiothorac Surg 2006, 29(Suppl. 1): S41-9.
74. Zund, G., Breuer, C.K., Shinoka, T., Ma, P.X., Langer, 74. R., Mayer, J.E., Vacanti, J.P. The in vitro construction of a tissue engineered bioprosthetic heart valve. Eur J Cardiothorac Surg 1997, 11(3): 493-7.
75. Freed, L.E., Vunjak-Novakovic, G. Microgravity tissue engineering. In Vitro Cell Dev Biol Anim 1997, 33(5): 381-5.
76. Shin, M., Ishii, O., Sueda, T., Vacanti, J.P. Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials 2004, 25(17): 3717-23.
77. Blom, A.S., Mukherjee, R., Pilla, J.J. et al. Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction. Circulation 2005, 112(9): 1274-83.
78. Lembcke, A., Dushe, S. Sonntag, S. et al. Changes in right ventricular dimensions and performance after passive cardiac containment. Ann Thorac Surg 2004, 78(3): 900-5.
79. Olsson, A. Bredin, F., Franco-Cereceda, A. Echocardiographic findings using tissue velocity imaging following passive containment surgery with the Acorn CorCap cardiac support device. Eur J Cardio-Thorac Surg 2005, 28(3): 448-53.
80. Chen, Q.Z., Harding, S.E., Ali, N.N., Lyon, A.R., Boccaccini, A.R. Biomaterials in cardiac tissue engineering: Ten years of research survey. Materials Science and Engineering R 2008, 59: 1-37.
81. Li, Z., Guan, J. Hydrogels for cardiac tissue engineering. Polymers 2011, 3(8): 740-61.
82. Akhyari, P., Fedak, P.W., Weisel, R.D., Lee, T.Y., Verma, S., Mickle, D.A., Li, R.K. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation 2002, 106(12, Suppl. 1): I137-42.
83. Zimmermann, W.H., Didie, M., Wasmeier, G.H. et al. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 2002, 106(12, Suppl. 1): I151-7.
84. Zimmermann, W.H., Melnychenko, I., Eschenhagen, T. Engineered heart tissue for regeneration of diseased hearts. Biomaterials 2004, 25(9): 1639-47.
85. Leor, J., Aboulafia-Etzion, S., Dar, A. et al. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 2000, 102(19, Suppl. 3): III56-61.
86. Kofidis, T., Lebl, D.R., Martinez, E.C., Hoyt, G., Tanaka, M., Robbins, R.C. Novel injectable bioartificial tissue facilitates targeted, less invasive, largescale tissue restoration on the beating heart after myocardial injury. Circulation 2005, 112(9, Suppl.): I173-7.
87. Lu, W.N., Lü, S.H., Wang, H.B. et al. Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. Tissue Eng Part A 2009, 15(6): 1437-47.
88. Laurie, G.W., Horikoshi, S., Killen, P.D., Segui-Real, B., Yamada, Y. In situ hybridization reveals temporal and spatial changes in cellular expression of mRNA for a laminin receptor, laminin, and basement membrane (type IV) collagen in the developing kidney. J Cell Biol 1989, 109(3): 1351-62.
89. Midwood, K.S., Williams, L.V., Schwarzbauer, J.E. Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol 2004, 36(6): 1031-7.
90. Gilbert, T.W., Sellaro, T.L., Badylak, S.F. Decellularization of tissues and organs. Biomaterials 2006, 27(19): 3675-83.
91. Mirsadraee, S., Wilcox, H.E., Korossis, S.A., Kearney, J.N., Watterson, K.G., Fisher, J., Ingham, E. Development and characterization of an acellular human pericardial matrix for tissue engineering. Tissue Eng 2006, 12(4): 763-73.
92. Badylak, S.F., Freytes, D.O., Gilbert, T.W. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater 2009, 5: 1-13.
93. Chang, Y., Chen, S.C., Wei, H.J. et al. Tissue regeneration observed in a porous acellular bovine pericardium used to repair a myocardial defect in the right ventricle of a rat model. J Thorac Cardiovasc Surg 2005, 130(1): 705-11.
94. Kochupura, P.V., Azeloglu, E.U., Kelly, D.J. et al. Tissue-engineered myocardial patch derived from extracellular matrix provides regional mechanical function. Circulation 2005, 112(9, Suppl.): I144-9.
95. Robinson, K.A., Li, J., Mathison, M. et al. Extracellular matrix scaffold for cardiac repair. Circulation 2005, 112(9, Suppl.): I135-43.
96. Badylak, S.F., Kochupura, P.V., Cohen, I.S. et al. The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium. Cell Transplant 2006, 15(Suppl. 1): S29-40.
97. Akhyari, P., Aubin, H., Gwanmesia, P. et al. The quest for an optimized protocol for whole-heart decellularization: A comparison of three popular and a novel decellularization technique and their diverse effects on crucial extracellular matrix qualities. Tissue Eng Part C Methods 2011, 17(9): 915-26.
98. Wainwright, J.M., Czajka, C.A., Patel, U.B., Freytes, D.O., Tobita, K., Gilbert, T.W., Badylak, S.F. Preparation of cardiac extracellular matrix from an intact porcine heart. Tissue Eng Part C Methods 2010, 16(3): 525-32.
99. Wang, B., Borazjani, A., Tahai, M. et al. Fabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cells. J Biomed Mater Res A 2010, 94(4): 1100-10.
100. Sarig, U., Machluf, M. Engineering cell platforms for myocardial regeneration. Expert Opin Biol Ther 2011, 11(8): 1055-77.
101. Shimizu, T., Yamato, M., Isoi, Y. et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 2002, 90(3): e40.
102. Miyahara, Y., Nagaya, N., Kataoka, M. et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006, 12(4): 459-6.
103. Masuda, S., Shimizu, T., Yamato, M., Okano, T. Cell sheet engineering for heart tissue repair. Adv Drug Deliv Rev 2008, 60(2): 277-85.
104. Zhang, Y., Thorn, S., DaSilva, J.N. et al. Collagen-based matrices improve the delivery of transplanted circulating progenitor cells: Development and demonstration by ex vivo radionuclide cell labeling and in vivo tracking with positron-emission tomography. Circ Cardiovasc Imaging 2008, 1(3): 197-204.
105. Dawson, E., Mapili, G., Erickson, K., Taqvi, S., Roy, K. Biomaterials for stem cell differentiation. Adv Drug Deliv Rev 2008, 60(2): 215-28.
106. Munoz, J., Zhou, Y., Jarrett, H.W. LG4-5 domains of laminin-211 binds alpha-dystroglycan to allow myotube attachment and prevent anoikis. J Cell Physiol 2010, 222(1): 111-9.
107. Eschenhagen, T., Eder, A., Vollert, I., Hansen, A. Physiological aspects of cardiac tissue engineering. Am J Physiol Heart Circ Physiol 2012, 303(2): H133-43.
108. Li, R.K., Yau, T.M., Weisel, R.D., Mickle, D.A., Sakai, T., Choi, A., Jia, Z.Q. Construction of a bioengineered cardiac graft. J Thorac Cardiovasc Surg 2000, 119(2): 368-75.
109. Morritt, A.N., Bortolotto, S.K., Dilley, R.J. et al. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 2007, 115(3): 353-60.
110. Dvir, T., Timko, B.P., Brigham, M.D. et al. Nanowired three-dimensional cardiac patches. Nat Nanotechnol 2011, 6(11): 720-5.
111. glycolic acid): Carbon nanofiber composites for myocardial tissue engineering applications. Acta Biomater 2011, 7(8): 3101-12.
112. Chachques, J.C., Trainini, J.C., Lago, N., Cortes-Morichetti, M., Schussler, O., Carpentier, A. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM trial): Clinical feasibility study. Ann Thorac Surg 2008, 85(3): 901-8.
113. RECATABI. REgeneration of CArdiac Tissue Assisted by Bioactive Implants [Accessed 2012 Oct 22]. Available at: www.recatabi.com.
114. Radisic, M., Park, H., Shing, H. et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A 2004, 101(52): 18129-34.
115. Llucià-Valldeperas, A., Sanchez, B., Soler-Botija, C. et al. Electrical stimulation of cardiac adipose tissue-derived progenitor cells modulates cell phenotype and genetic machinery. J Tissue Eng Regen Med 2013, Epub ahead of print.
116. Eschenhagen, T., Fink, C., Remmers, U. et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: A new heart muscle model system. FASEB J 1997, 11(8): 683-94.
117. Sanchez, B., Guasch, A., Bogonez, P. et al. Towards on line monitoring the evolution of the myocardium infarction scar with an implantable electrical impedance spectrum monitoring system. 34th Annu Int IEEE EMBS Conf (Aug 28-Sept 1, San Diego) 2012, ThC08.1.
118. Gálvez-Montón, C., Prat-Vidal, C., Sánchez, B., Puig-Sanvicenç, V., Bragós, R., Bayes-Genis, A. On-line monitoring of myocardial ischemia after a bioactive smart patch implantation in swine. 4th Int Congr Stem Cells Tissue Formation (July 18-20, Dresden) 2012, Abst SDT-31.
119. Shen, Y.H., Shoichet, M.S., Radisic, M. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater 2008, 4(3): 477-89.
120. Lai, P.H., Chang, Y., Chen, S.C., Wang, C.C., Liang, H.C., Chang, W.C., Sung, H.W. Acellular biological tissues containing inherent glycosaminoglycans for loading basic fibroblast growth factor promote angiogenesis and tissue regeneration. Tissue Eng 2006, 12(9): 2499-508.
121. Zachman, A.L., Crowder, S.W., Ortiz, O. et al. Pro-angiogenic and antiinflammatory regulation by functional peptides loaded in polymeric implants for soft tissue regeneration. Tissue Eng Part A 2013, 19(3-4): 437-47.
122. Sales, V.L, Mettler, B.A., Lopez-Ilasaca, M., Johnson, J.A. Jr., Mayer, J.E. Jr. Endothelial progenitor and mesenchymal stem cell-derived cells persist in tissue-engineered patch in vivo: Application of green and red fluorescent protein-expressing retroviral vector. Tissue Eng 2007, 13(3): 525-35.
123. Jin, J., Jeong, S.I., Shin, Y.M. et al. Transplantation of mesenchymal stem cells within a poly(lactide-co-epsilon-caprolactone) scaffold improves cardiac function in a rat myocardial infarction model. Eur J Heart Fail 2009, 11(2): 147-53.
124. Badylak, S.F., Taylor, D., Uygun, K. Whole-organ tissue engineering: Decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 2011, 13: 27-53.
125. Weymann, A., Loganathan, S., Takahashi, H. et al. Development and evaluation of a perfusion decellularization porcine heart model-Generation of 3-dimensional myocardial neoscaffolds. Circ J 2011, 75(4): 852-60.
126. Remlinger, N.T., Wearden, P.D., Gilbert, T.W. Procedure for decellularization of porcine heart by retrograde coronary perfusion. J Vis Exp 2012, 6(70): e50059.
127. Gálvez-Montón, C., Prat-Vidal, C., Roura, S. et al. Transposition of a pericardial-derived vascular adipose flap for myocardial salvage after infarct. Cardiovasc Res 2011, 91(4): 659-67.
128. Gálvez-Montón, C., Prat-Vidal, C., Roura, S. et al. Post-infarction scar coverage using a pericardial-derived vascular adipose flap. Pre-clinical results. Int J Cardiol 2013, 166(2): 469-74.
129. Bayes-Genis, A., Gálvez-Montón, C., Prat-Vidal, C., Soler-Botija, C. Cardiac adipose tissue: A new frontier for cardiac regeneration? Int J Cardiol 2013, 167(1): 22-5.